A new sleeping tablet is being developed by scientists, which will also serve to tackle obesity and enhance the memory power. This Orexin-RA-1 tablet will also be devoid of other side effects like drowsiness during the daytime, in addition to addiction. The hormone orexin which is directly connected to sleeping disorders and paralysis will be targeted by the new pill.
The pill has already been tested on rats, which performed better in tests the next day when compared to rats which were given conventional sleeping tablets. The REM of the new pill, which is the dream phase during the sleep was seen to be higher, serving to enhance memory.
The drug is being developed by Actelion. As the new tablet orexin is connected to eating habits, it can also be used for treating obesity. As much as 20% to 30% of the human population reportedly suffers from insomnia. The new drug may hit the market in 2012 if the tests are successful.